Ebenbuild raises €2.5M Seed round

31 March 2022· Munich, Germany· health, ai, biotech, b2b, pure_software

The seed funding will be used to further develop the company's lung simulation prototype, expand the team, and work toward gaining medicinal product approval for clinical application in ICU mechanical ventilation.

Investors

LeadBayern Kapital
Also participating
High-Tech GründerfondsTechFoundersIntel Ignite

About Ebenbuild

Stage
Seed
Headquarters
Munich, Germany
Founded
2019
Team Size
21–50
Sectors
healthaibiotechb2bpure_software

Source: https://www.htgf.de/en/htgf-seed-investment-ebenbuild/